Loading…
Loading…
MSPR does not currently pay a dividend.
See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.
Click below to see what's inside, then upgrade to unlock for MSPR and 80,000+ other tickers.
See exactly how MSPR's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for MSPR and 80,000+ other tickers.
MSP Recovery, Inc. specializes in healthcare claims recovery and data analytics, serving clients throughout the United States and Puerto Rico. The company provides extensive services, enabling itself, associated parties, and third-party organizations to effectively pursue their rights for healthcare claim recovery. A notable offering is its "Chase to Pay" service, which aids healthcare providers in accurately identifying the correct primary insurer at the time of service, thereby preventing mistaken payments. Furthermore, MSP Recovery, Inc. developed "LifeWallet," a platform designed to help…
MSP Recovery (NASDAQ: MSPR - Get Free Report) and CareCloud (NASDAQ: CCLD - Get Free Report) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their profitability, earnings, analyst recommendations, risk, valuation, dividends and institutional ownership. Earnings and Valuation This table compares MSP Recovery
MSP Recovery (NASDAQ: MSPR - Get Free Report) and iRhythm Technologies (NASDAQ: IRTC - Get Free Report) are both medical companies, but which is the better stock? We will compare the two companies based on the strength of their risk, analyst recommendations, institutional ownership, valuation, dividends, earnings and profitability. Profitability This table compares MSP Recovery and iRhythm
10x Genomics (NASDAQ: TXG - Get Free Report) and MSP Recovery (NASDAQ: MSPR - Get Free Report) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, earnings, analyst recommendations, institutional ownership, profitability, valuation and risk. Risk and Volatility 10x Genomics has a beta
SOPHiA GENETICS (NASDAQ: SOPH - Get Free Report) and MSP Recovery (NASDAQ: MSPR - Get Free Report) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, valuation, profitability, earnings, risk, institutional ownership and analyst recommendations. Valuation and Earnings This table compares SOPHiA
MSP Recovery, Inc. (NASDAQ: MSPR - Get Free Report) saw a large growth in short interest during the month of December. As of December 15th, there was short interest totaling 1,568,727 shares, a growth of 231.4% from the November 30th total of 473,363 shares. Based on an average daily volume of 5,215,219 shares, the days-to-cover ratio